Intelligent
ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
SHANGHAI,Feb. 25,2025-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chin
India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution
New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t
G-P Expands Availability of G-P Gia™; Welcomes Leaders to the Next Era of HR
The smartest AI global HR advisor,G-P Gia,thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states
Baidu Acquires JOYY's Live Streaming Business in China
BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid
Cedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho
The company will be the first 100% Brazilian mining company to verticalize its operations and intends to invest R$3.6 billion in the project
GILF Shortlisted in Catalog of Guangdong's Nationwide Trade Initiative (2025), Starting New Procurement Season in March
ZHONGSHAN,China,Feb. 25,2025-- Recently,the official website of the Department of Commerce of Guangdong Province released the Catalog of Guangdong\'s Nationwide Trade Initiative (2025). After submissi
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)
SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr
Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25,2025 GUANGZHOU,China,Feb. 25,2025--Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leading
Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android
Enables Users to Boost Productivity with AI-Powered Summaries,Cross-Document Insights,and Instant Data Extraction Across Mobile Device